Recon: FDA approves J&J and Legend’s CAR-T cancer therapy; Gilead lands CRL for HIV drug over glass vial concerns
ReconJoanne S. Eglovitch
Biologics/ biosimilars/ vaccinesBiotechnologyDiagnostics/IVDsGlobalMedical DevicesNorth AmericaPharmaceuticalsRegulatory Intelligence/Policy